Successful dupilumab treatment for omalizumab-refractory chronic spontaneous urticaria with GATA3+ cell infiltration.
Shirai K, Suzuki T, Nagakura Y, Honda T
European Journal of DermatologyIn the feed 27 Jul 2026, issue 2026 Jun 01, added to PubMed 27 Jul 2026
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42507409 · DOI 10.1684/ejd.2026.5084